Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Due to Large Core Infarction
NCT07333950Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jan 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in basilar artery occlusion (BAO) and ischemic stroke (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Modified Rankin Scale 0-3 at 90 days. Planned start Jan 2026; status: not yet recruiting.
02
Conditions
basilar artery occlusion (BAO)ischemic stroke
Beyond the preview
Go deeper on NCT07333950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07333950.